Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT00095550
Eligibility Criteria:
Inclusion Criteria:
* Willing to provide written informed consent
* Subjects must have uncontrolled hypertension defined as:
* average systolic blood pressure between 160 mmHg and 180 mmHg (while diastolic blood pressure is less than 110 mmHg) or
* average diastolic blood pressure between 100 mmHg and 110 mmHg (while systolic blood pressure is between 130 mmHg and 180 mmHg)
* Subjects must be willing to discontinue their antihypertensive medication, if applicable.
* Men and women, ages 18 and older will be included.
* Women of childbearing potential (WOCBP) must be using an adequate method of contraception to avoid pregnancy throughout the study and for up to one week after the study in such a manner that the risk of pregnancy is minimized. WOCBP must have a negative serum or urine pregnancy test within 72 hours prior to the start of study medication.
Exclusion Criteria:
* Women who are pregnant or breastfeeding
* Known or suspected secondary hypertension
* Hypertension emergencies or stroke within the past 12 months.
* Heart attack, angina or bypass surgery within the past six months.
* Significant kidney disease
* Significant liver disease
* Systemic lupus erythematosus
* Gastrointestinal disease or surgery that interfere with drug absorption
* Cancer during the past five years excluding localized squamous cell or basal cell carcinoma of the skin
* Currently pregnant or lactating
* Mental condition (psychiatric or organic cerebral disease) rendering the subject unable to understand the nature, scope, and possible consequences of the study
* Drug or alcohol abuse within the last five years
* Known allergy to irbesartan or diuretics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00095550
Study Brief:
Protocol Section:
NCT00095550